Impact of methocarbamol on opioid use after primary ventral and inguinal hernia repair

Multimodal analgesia is now a mainstay of perioperative care. Our aim is to assess the impact of adding methocarbamol on opioid use for patients undergoing primary ventral (umbilical and epigastric) hernia repair (PVHR) and inguinal hernia repair (IHR). Retrospective review of patients undergoing PV...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American journal of surgery 2023-12, Vol.226 (6), p.813-816
Hauptverfasser:	Crosier, Caitlin, Hammond, Brooke, Carbonell, Cecilia, Hoffman, Katherine, Desai, Shivani, Blackhurst, Dawn, Carbonell, Alfredo M., Love, Michael W., Cobb, William S., Warren, Jeremy A.
Format:	Artikel
Sprache:	eng
Schlagworte:	Abdomen Analgesia Analgesics Chronic obstructive pulmonary disease Diabetes Gastrointestinal surgery Hernia Hernias Inguinal hernia repair Laparoscopy Methocarbamol Multimodal pain Narcotics Nonsteroidal anti-inflammatory drugs Opioid Opioids Pain Patient satisfaction Prescriptions Primary ventral hernia repair Recovery (Medical) Surgeons
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Multimodal analgesia is now a mainstay of perioperative care. Our aim is to assess the impact of adding methocarbamol on opioid use for patients undergoing primary ventral (umbilical and epigastric) hernia repair (PVHR) and inguinal hernia repair (IHR). Retrospective review of patients undergoing PVHR and IHR who received methocarbamol, propensity score matched in a 2:1 fashion to patients not receiving methocarbamol. Fifty-two PVHR patients receiving methocarbamol were matched to 104 control patients. Study patients were prescribed fewer opioids (55.8 vs 90.4%; p
ISSN:	0002-9610 1879-1883
DOI:	10.1016/j.amjsurg.2023.06.024